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Summ81-y 
Numerous substrates  are tyrosine phosphorylated upon CD2 stimulation of human Jurkat T 
cells using a mitogenic pair of CD2 monoclonal antibodies, including the phospholipase C (PLC)3'- 
1-p35/36 complex. Most of these substrates are identically tyrosine phosphorylated after CD3 
ligation, suggesting that both stimuli share the same biochemical pathway. We show, however, 
in this report that a 63-kD protein is specifically phosphorylated on tyrosine residues after ligation 
of the CD2 molecule. The tyrosine phosphorylation of p63 can be induced independently of 
other substrates when using a single CD2 mAb recognizing the D66 epitope of the molecule. 
Importantly, this CD2-induced tyrosine phosphorylation of p63 can also occur in the absence 
of the CD3~" chain membrane expression,  and is also distinct from the protein tyrosine kinases 
p56  ~  and p59f~.  We demonstrate, moreover, that p63 is physically linked with PLC3r-1 and 
p35/36 upon CD2 stimulation. Finally, we also show that a 62-kD protein coimmunoprecipitating 
with the p21ras GTPase activating protein (GAP) is heavily tyrosine phosphorylated only after 
CD2 stimulation. This ultimately suggests that p63 may represent in fact the 62-kD protein 
that associates with GAP after tyrosine phosphorylation. Taken together, these results demonstrate 
the occurrence in Jurkat cells of a tyrosine kinase pathway specifically  coupled to the CD2 molecule. 
They also suggest a function of the p62-GAP-associated protein as a link between PLC3,-1 and 
p21ras activation pathways  after  CD2 activation. 
T 
he function of CD3 as an integral part of the antigen- 
specific receptor of T lymphocytes is well established (1). 
However, the real function of CD2 is still a debatable ques- 
tion. It is actually considered as a CD3-TCR alternative ac- 
tivation pathway promoting intercellular adhesion as well as 
T  cell activation (2). Although not specific (CD2 ligands, 
CD58 and CD59, are ubiquitous molecules) (3), CD2 rec- 
ognition has  been  reported  to  positively regulate  CD3- 
TCR-mediated activation signals (4) suggesting that it may 
be a costimulatory signal for T cells during the antigen-specific 
recognition process. This assumption, about a close link be- 
tween these two T  cell  activation pathways,  was further 
confirmed by the finding that CD2-mediated T cell activa- 
tion by specific antibodies required a functional CD3-TCR 
complex at the T cell surface (5). Particularly involved in this 
last phenomenon  seems to be the CD3~'chain which is known 
to be a key element responsible for cell signal transduction 
through the antigen-specific receptor of T lymphocytes (6-8). 
From all these reasons, it was postulated that CD2 and CD3 
shared a common activation pathway. 
This hypothesis was strengthened by the discovery that 
both CD3 and CD2 molecules apparently triggered the same 
cascade of early biochemical events, and especially the phos- 
pholipase C (PLC)  1 activation pathway (9, 10). Indeed, it has 
been demonstrated that the earliest event after CD3 or CD2 
ligation with specific mAbs consisted in the rapid phosphory- 
lation on tyrosine residues of numerous substrates.  Among 
them is a 145-kD substrate, identified as PLC'y-1, one of the 
main isoforms of PLC in human T lymphocytes whose ac- 
tivity is increased by tyrosine phosphorylation (11, 12). Acti- 
vated PLC3'-I would be then responsible for the observed 
accumulation of the second messengers inositol(1,4,5)-tris- 
phosphate (IP3) and diacylglycerol (DAG). IP3 and DAG are, 
respectively, involved in intracellular  free calcium elevation 
and protein kinase C activation, two metabolic events crit- 
ical for the appearance of downstream biological effects after 
CD3 or CD2 stimulation, i.e., IL-2 production and T  cell 
1 Abbrrviations used in this paper: IP3, inositol(1,4,5)-trisphosphate; PLC, 
phospholipase C; PTK, protein tyrosine kinase. 
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and CD2 were coupled to the same as yet unidentified non- 
receptor tyrosine kinase, responsible for PLC3,-1 tyrosine phos- 
phorylation. Several protein tyrosine kinases (PTKs) have been 
proposed for this coupling. This includes members of the 
src family of membrane-associated  PTK such as p56 ~k, found 
to be noncovalently associated with the CD4 or CD8 cyto- 
plasmic domain (15) and activated after CD3 or CD2 cell 
stimulation (16-18),  as well as the TCR ~" chain-associated 
kinase p59f~ (19). The potential role of another ~'-assodated 
tyrosine phosphorylated protein with PTK activity, ZAP-70, 
was also envisaged (20). It has been suggested that both types 
of kinases  (src family PTKs and ZAP-70)  may interact to 
mediate TCR signaling. 
Numerous epitopes distinguished by various sets of mAbs 
are present on the CD2 molecule of human T  cells. Some 
of them are already highly expressed on resting T cells. Others 
are only weakly detected by the corresponding mAbs partly 
because of their masking with sialic acid residues on resting 
T cells (21). Meanwhile, a full activation via the CD2 mole- 
cule in vitro, leading to an activation of the PLC pathway, 
as well as late functional events,  has been demonstrated to 
require the simultaneous ligation of these two kinds of epi- 
topes (22). The involvement of CD2 conformational changes 
induced by the simultaneous binding of mAbs has been put 
forward, In this report, we demonstrate that stimulation of 
the CD2 molecule by a mitogenic pair of CD2-specific mAbs, 
as well as by a single CD2 mAb recognizing the cryptic epi- 
tope of the CD2 molecule expressed on Jurkat T cells, is able 
to specifically induce the tyrosine phosphorylation of a 63- 
kD protein. Importantly, we present evidence that p63 tyro- 
sine phosphorylation appears  even in the absence of CD3~" 
chain membrane expression.  Our results also revealed that 
tyrosine phosphorylation of  p63 can be induced independently 
of the phosphorylation of PI.C3,-1, suggesting that both pro- 
teins are phosphorylated by distinct tyrosine kinases.  In ad- 
dition, they also suggest that a complex containing PI.C3,-1, 
its associated 35/36-kD protein and p63 can be formed upon 
CD2 stimulation. Ultimately, using coimmunoprecipitation 
experiments, we show that p63 may represent in fact the pre- 
viously described p62 GAP-associated protein. 
Materials  and Methods 
Cells.  CD2+CD3 + Jurkat cells, clone E-6.1, were grown in 
RPMI 1640 medium (Flow Laboratories,  Irvine, UK) supplemented 
with 10% FCS, penicillin (50 U/ml), streptomycin (50 #g/ml), 
2 mM r-glutamine, and 1 mM sodium pyruvate, at a density of 
0.5  x  106 cells/ml. CD2+CD3 -  31.13 Jurkat  cell clone (23), 
kindly given by Dr. A. Alcover (Institut  Pasteur, Paris, France), 
was cultured in the same conditions. A CD2-CD3- Jurkat cell 
clone was obtained by limiting dilution of 31.13 cells followed  by 
immunofluorescence analysis to  select CD2-  cells. For  im- 
munofluorescence  studies, an indirect staining  procedure with FITC- 
conjugated af~ipure goat anti-mouse antibodies (Immunotech In- 
ternational, Marseille, France) was used. Fluorescence  analysis  was 
performed on a FACScan  |  cell analyzer (Becton Dickinson & Co., 
Mountain View, CA). 
MonodonalAntibodies.  mAb UCHT1 (IgG1), specific  for CD3~ 
chain, was obtained from Dr. P. C. L. Beverley  (Imperial Cancer 
Research, London, UK). CD2 mAbs Xll (IgG1), D66 (IgG2b), 
0275 (IgG1), G144 (IgM), and GT2 (IgG1) were previously de- 
scribed (21, 22, 24-26). mAbs Xll and 0275 recognize the previ- 
ously described  Tl1.1 epitope of  the CD2 molecule (2). mAbs D66 
and G144 are specific for a cryptic epitope on resting T cells be- 
cause of its partial covering with sialic acid residues and which is 
completely unmasked after T cell activation. For all stimulation 
experiments, these mAbs were used at 1:500 dilution of an ascitic 
fluid. The 1C5H5 mAb against the TCR c~ chain of a human T 
cell clone was produced in our laboratory (27) and used as a con- 
trol. Anti-PLC3,-1 mAb, antiphosphotyrosine mAb (4G10), and 
rabbit antiserum against COOH-terminal residues of p56  ~k and 
rabbit antiserum recognizing p59~ were purchased from UBI Inc. 
(Lake Placid, NY). Anti-GAP mAb was obtained from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA). 
Cell Stimulation and Tyrosine Phosphorylation Analysis.  Cells  (5 
x  106) were washed in RPMI containing 10 mM Hepes, pH 7.2, 
equilibrated for 10 min at 37~  and then incubated for various 
periods of time at 37~  in medium alone or in the presence of 
different stimulating agents. Activation was stopped by brief cen- 
trifugation, and cells were immediately lysed for 40 min in lysis 
buffer (20 mM Tris-HC1, pH 7.5, 1 mM EDTA, 140 mM NaC1, 
1% NP-40, 50 U/ml aprotinin, I mM sodium orthovanadate, and 
1 mM PMSF) at 4~  Nuclei and cellular debris were removed 
by centrifugation. Postnuclear superuatants were then diluted in 
Laemmli  sample  buffer (500 mM Tris-HC1, pH 6.8, 10% SDS, 10% 
glycerol, 5% 2-ME, and 10% bromophenol blue) and boiled for 
5 min before SDS-PAGE analysis.  Proteins were electrophoretically 
transferred for 1 h at 65 V to nitrocellulose sheet (Schleicher & 
Schuell, Dassel, Germany), and blots were hybridized with anti- 
PLC'y-1 (0.1/zg/ml) or antiphosphotyrosine mAb (0.2 #g/ml) be- 
fore addition of goat anti-mouse antiserum labeled with peroxi- 
dase. Reaction was revealed with an enhanced chemiluminescence 
system (ECL; Amersham, Paris, France) according to the supplier's 
instructions. 
Immunoprecipitation Experiments.  For immunoprecipitation ex- 
periments, cell lysates of 107 stimulated cells were prepared as 
above except that a lysis buffer containing 1% digitonin instead 
of NP-40 and lacking EDTA was used. Cellular debris was removed 
by centrifugation, and lysates were precleared for 1 h with 20 #1 
of packed protein A-Sepharose beads (Sigma Chemical Co., St. 
Louis, MO). Precleared  lysates  were then incubated overnight with 
2 #g of anti-PLC3~-I mAb or 1 #g of anti-GAP mAb or rabbit 
antiserum against p56  ~k or p59f~" tyrosine kinases. Immunoprecipi- 
rates were then recovered by incubation with 20/zl of protein 
A-Sepharose beads for 60 min at 4~  and washed three times in 
lysis  buffer. The proteins were then eluted and dissolved  by boiling 
for 5 min in Laemmli sample buffer, and subsequently resolved  by 
SDS-PAGE. Western blot analysis was then performed using an- 
tiphosphotyrosine mAb 4G10. 
Inositol Phosphate Production Measurement.  Jurkat cells (106/ml) 
were labeled overnight with 5 #Ci/ml myo-[2-3H]inositol (ICN 
Flow, Orsay, France)  in inositol-free  medium containing 10% FCS, 
2 mM r-glutamine, 1 mM sodium pyruvate, 50 U/ml penicillin, 
and 50/zg/ml streptomycin.  After two washes  in KPMI containing 
10 mM Hepes, pH 7.2, cells were incubated for 20 min with 10 
mM LiC1 at 37~  Aliquots of 106 cells were then stimulated with 
the indicated mAbs for the indicated period of time at 37~  Reac- 
tion was stopped by successive  addition of 50 #1 NaOH 0.1 N con- 
taining 0.1% Triton X-100, 50 #1 HC1, 0.1 N and 0.2 ml H20. 
The extraction procedure was continued in borosilicate  glass tubes 
by the addition of 1.5 ml chloroform/methanol (1:2). The organic 
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HzO and 0.5  ml chloroform,  and the tubes centrifuged  10 min 
at 400 g.  1 ml of the aqueous phase was then applied simultane- 
ously with 4 ml of a 5-mM cold myo-inositol on 1 ml Dowex AG 
1-X8 anion-exchange resin in the formate form (Bio-Rad Labora- 
tories, Richmond, CA), equilibrated with 0.1 M formic acid. The 
columns were then washed with 10 ml 0.1 M formic acid and the 
IP eluted with 5 ml 0.1 M formic acid plus 1.2 M ammonium for- 
mate. The eluted radioactivity  was quantified by liquid scintilla- 
tion counting in aqueous scintillant (ACS II; Amersham) and the 
results expressed in dpm (24). 
Results 
Stimulation  of  Jurkat  T  Cells through the CD3-TCR  Com- 
plex or the CD2 Molecule Induces a Different Pattern of Protein 
Tyrosine Phosphorylation.  CD3-TCR  and  CD2  activation 
pathways are thought  to be closely linked.  First,  they have 
been shown to trigger the same cascade of biochemical events 
including activation of early PTKs, inositol phosphate produc- 
tion, and increases in intracellular free calcium concentration. 
Second, it is now generally admitted that the CD2-induced 
T  cell activation  needs  functional  CD3-TCR  complex ex- 
pressed at the cell surface (8,  10).  However, as depicted in 
Fig. 1, the patterns of proteins tyrosine phosphorylated after 
CD3  or CD2 ligation  with  the CD3 mAb UCHT1  (Fig. 
1, top), or with the CD2 mitogenic pair ofmAbs X11+D66 
(Fig.  1,  bottom),  were not identical.  Indeed,  apart from the 
145-,  120-, 116-, 100-, 80-, 75-, and 35/36-kD tyrosine phos- 
phorylated proteins induced by both stimuli,  we could no- 
tice a 66-kD doublet strongly tyrosine phosphorylated over 
the background level only after CD3 stimulation. Conversely, 
a 63-kD tyrosine phosphorylated protein was only observed 
after CD2 ligation. This suggested that different PTKs could 
be activated depending on whether Jurkat cells were stimu- 
lated through CD3-TCR or CD2 molecules. One should no- 
tice here that the 145-kD band observed after CD3 or CD2 
stimulation corresponded to tyrosine phosphorylated PI.C'y-1 
since a single 145-kD protein was revealed by anti-PLC3,-1 
mAb in antiphosphotyrosine immunoprecipitates of CD3 or 
CD2-activated Jurkat  cells (data  not  shown). 
Delayed kinetics of tyrosine phosphorylation have been pre- 
viously evidenced after the activation of PBL with CD2 mAbs 
as compared with  CD3  stimulation  (28).  The  time course 
experiments shown in Fig. I demonstrate that the maximum 
response always occurred later after CD2  stimulation  with 
the mAb pair X11+D66.  Usually it was found to peak be- 
tween 3  and 5 min after the addition  of the CD2 pair.  In 
the  same assay  conditions,  tyrosine phosphorylations  after 
CD3 stimulation  peaked very early (between 15 and 30 s). 
It is also clear from Fig.  1 that for a given stimulus, all pro- 
teins, including p66 and p63, shared the same tyrosine phos- 
phorylation  kinetic. 
Tyrosine Phosphorylation of p63 Is Induced upon Stimulation 
of the D66 Epitope on the CD2 Molecule.  As previously men- 
tioned, various epitopes distinguished by different mAbs are 
present on the CD2 molecule of human T  cells.  Owing to 
the apparent specificity of p63 tyrosine phosphorylation after 
CD2 stimulation, we tested the effects of other pairs of CD2 
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Figure  1.  Different  patterns oftyrosine  phosphorylated  proteins are in- 
duced after CD3 or CD2 stimulation. Jurkat cells (5 x  106)  were stimu- 
lated with the CD3 mAb UCHT1 (top)  or with the CD2 mAbs  Xll +D66 
(bottom) for the indicated times. Total  cell extracts were resolved  on a 8% 
polyacrylamide  gel, transferred to nitrocellulose, and immunoblotted  with 
antiphosphotyrosine mAb 4G10. Positions  of molecular size markers are 
indicated. Exposition times  were 10 s for each  membrane. Parallelblotting 
using anti-PLC',/-1 mAb revealed no change in the amount of PLC',/-1 
for each stimulation time, indicating that the same quantity of cellular 
extract was loaded for each sample (not shown). 
mAbs. mAb 0275 recognizes the same epitope as Xll  and 
mAb G144 the same as D66 (25, 26). mAb GT2 recognizes 
a third epitope, as evidenced by the lack of competitive binding 
with the mAbs named above (22). Cytofluorometry analysis 
of Jurkat cells after labeling with each of these CD2 mAbs 
as compared with CD3 mAb UCHT1 is presented in Fig. 
2. High binding of mAbs Xll and 0275, intermediate binding 
of GT2,  and low binding  of mAbs D66 or G144 could be 
evidenced. 
Fig.  3  A  shows  that  different  couples  of CD2  mAbs t_ 
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Figure  2.  Immunofluorescence  analysis ofJurkat T cells with different 
CD2 mAbs. Cells were stained for 30 min with the indicated CD2 mAb 
(XI1, D66, 0275, (7,144, GT2) or with the CD3 mAb UCHT1.  An ir- 
relevant mAb, used as the negative control, is also shown in each panel. 
All mAbs were used as a 1:400 dilution of an ascitic fluid. Bound mAbs 
were revealed using goat anti-mouse FITC conjugate and the fluorescence 
analyzed on a FACScan  |  cell analyzer. 
(Xl1+ D66, Xl1+ G144, GT2 + G144, and 0275 + G144) were 
able to induce the tyrosine phosphorylation of p63 protein. 
None of  them could, however, phosphorylate the 66-kD dou- 
blet observed after CD3 stimulation.  Interestingly,  we can 
see from Fig. 3 A that p63-induced phosphorylation appar- 
ently correlated with the presence in the studied combina- 
tion of mAb D66 or G144 to CD2 receptor. The same results 
were obtained when using purified CD3 and CD2 mAb in- 
stead of  ascitic fluid (data not shown). We therefore analyzed 
the effect of single CD2 mAb on protein tyrosine phosphory- 
lation in Jurkat cells. We were surprised to discover that D66 
and G144 could induce p63 tyrosine phosphorylation when 
used alone (Fig, 3 B). The fact that neither the single CD2 
mAb Xll, nor 0275,  nor control ascite fluid, were able to 
induce the p63 phosphorylation demonstrated its specific  in- 
duction by stimulating the D66 epitope on the CD2 mole- 
cule. It seemed, therefore, that stimulating D66 epitope could 
activate a PTK acting on p63. 
Importantly, these results also pointed out that p63 tyro- 
sine phosphorylation occurred independently of  PLCT-1 phos- 
phorylation.  Indeed, mAb pairs Xl1+ G144 and GT2 + G144 
C 
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Figure  3.  p63 tyrosine phosphorylation is induced upon stimulation 
of the D66 epitope on the CD2 molecule. (.4) Effect of various CD2 mAbs 
pairs on tyrosine phosphorylation pattern in Jurkat T  cells. Jurkat cells 
were unstimulated (-), or stimulated with the CD3 mAb UCHT1  for 
1 min, or various  CD2 mAbs pairs for 5 min: X11+D66,  Xll+G144, 
X11+GT2, GT2+G144, or O275+G144.  After cells lysis, proteins were 
separated by SDS-PAGE (12%  polyacrylamide gel) and visualized by im- 
munoblotting with antiphosphotyrosine mAb 4G10. (B) Induction of p63 
tyrosine phosphorylation  by a single CD2 mAb. Control ascitic fluid (mAb 
1C5H5),  single CD2 mAb Xli, D66, 0275, or G144 were used for stim- 
ulation experiments ofJurkat T cells (5  x  106Aample). After lysis, post- 
nuclear supernatants  were loaded on a 8% polyacrylamide  gel, and sepa- 
rated proteins were revealed by Western blotting using antiphosphotyrosine 
mAb  4G10.  (C)  IP  production  after  CD2  stimulation.  Jurkat  cells 
(106/ml) were labeled with myo-[2-3H]inositol and divided in aliquots (106 
cells/sample)  which were then stimulated with UCHT1  for 1 min,  or 
CD2  mAbs pairs  X11+D66,  X11+G144,  X11+GT2,  GT2+G144,  or 
O275+G144 for 5 min, or single CD2 mAb Xll, D66, O275, or G144 
for 5 min, or were left unstimulated (-). IPs were measured as described 
in Materials  and Methods.  Results are expressed in dpm as the mean of 
three separate experiments. 
could tyrosine phosphorylate p63 without inducing any de- 
tectable tyrosine phosphorylation of the 145-kD band corre- 
sponding  to PLCT-1 (Fig. 3 A). In the same way, D66 or 
G144 mAbs used alone triggered p63 but not PLC3,-1 tyro- 
sine phosphorylation (Fig. 3 B). This latter result was con- 
firmed by the fact that neither Xl1+ G144 and GT2 + G144 
pairs, nor mAbs D66 or G144 used alone, could trigger ino- 
sitol phosphate production (Fig. 3 C), as compared with the 
pairs that were able to trigger the phosphorylation of  PLC3,-1 
(see Fig. 3 A). Accordingly, in parallel experiments, we found 
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brane CD3-TCR expression. 31.13 cells (phenotype CD2 +CD3-) were 
stimulated  with the CD3 mAb UCHT1 for  1 min, or the mAb pair 
X11+D66 for 5 min, or were left unstimulated (-). After lysis, total cel- 
lular extracts were run on a 8% SDS-PAGE. Proteins were then revealed 
by immunoblotting  using antiphosphotyrosine mAb 4G10. As a negative 
control, the same experiments were performed in a variant cell line de- 
rived from 31.13 by limiting dilution, and lacking cell surface CD2. 
a sustained intracellular free calcium increase only with those 
combinations leading to tyrosine phosphorylation of PLCy-1 
(data  not shown). 
p63  Tyrosine Phosphorylation Occurred Independentl2/ of the 
CD3-TCR Complex,  Complete activation process of  Jurkat 
T  cells through the CD2 pathway,  including early protein 
tyrosine phosphorylation, followed by inositol phosphate 
production, increased in intracellular free calcium concentra- 
tion and lately IL-2 synthesis, is known to require functional 
CD3-TCR complex at the cell surface. Particularly required 
for that process seems to be the CD3~'chain which is thought 
to be responsible, at least in part, for signal transduction medi- 
ated after the stimulation of the CD3-TCR molecular com- 
plex (6, 7). Whether or not tyrosine phosphorylation of p63 
was dependent on CD3-TCR expression seemed, therefore, 
an important question to answer. For that purpose, we used 
a previously described  Jurkat cell variant, termed 31.13, lacking 
the TCR/3 chain gene and that fails to express any mem- 
brane CD3-TCR complex or CD3~'chain (8, 23). As shown 
in Fig. 4 (left), stimulation of this cell variant with the CD2 
mAb pair Xl1+ D66 also induced the tyrosine phosphoryla- 
tion of p63, although this induction was usually weaker as 
in the parental cell line. Importantly, it was not accompanied 
by the tyrosine phosphorylation of the other substrates  ob- 
served in the wild type of Jurkat cells (see Fig.  1, bottom). 
In the same cell line, the CD3 mAb UCHT1 did not stimu- 
late any phosphorylation, a finding which was consistent with 
the absence of cell-surface CD3. As a control, we have also 
used in this experiment a cell clone, selected from the 31.13 
variant, and lacking CD2 surface expression (data not shown). 
No tyrosine phosphorylation of p63 could be observed in 
this clone after stimulation with the CD2 mAb pair Xl1+ D66 
(Fig. 4, right). Altogether these findings demonstrated that 
p63 tyrosine phosphorylation only depended on the CD2 
pathway and did not require CD3-TCR or ~" chain expres- 
sion. These results underlined again the independence of the 
p63 tyrosine phosphorylation pathway since no PLC'y-1 phos- 
phorylation could be observed after CD2 stimulation of the 
31.13 variant. 
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Figure 5.  p63 coimmunoprecipitates with PI.Cq/-1 
and is distinct from a tyrosine phosphorylated  form 
of p56  ~i or p59fv' kinases. (a) Jurkat cells (107 for each 
point) were unstimulated (-), or activated with the 
CD3 mAb UCHT1 for 1 min, the CD2 mAb pair 
X11+D66 or the mAb D66 alone for 5 min. Cells 
were  then  lysed  in  a  lysis buffer  containing 1% 
digitonin  and precleared lysates were immunoprecipi- 
rated with anti-PI.C3,-1  mAb. Immune  complexes  were 
resolved by SDS-PAGE on a 8% acrylamide gel, and 
Western blot analysis  using antiphosphotyrosine mAb 
4G10 was performed.  Positions of coimmunopreci- 
pitating P1-C3,-1, p35/36, and p63 are indicated. No 
bands except mAb H chains could be detected in im- 
munoprecipitates performed with an irrelevant mAb 
(not shown). (b) In a separate experiment, Jurkat cells 
were left unstimulated (lane 1) or were activated using 
the CD2 mAb pair Xl1+ D66 (lanes 2, 3, and 4), and 
treated as above. Lysates were then immunoprecipi- 
tated with anti-PLC~-I mAb (lanes I and 2) or rabbit 
antiserum recognizing the COOH-terminal residues 
of p56~ (lane 3) or rabbit antiserum specific  for p59f~ 
(lane 4). Immunoprecipitates  were resolved by SDS- 
PAGE and revealed using antiphosphotyrosine  mAb 
4G10. Positions of tyrosine phosphorylated bands of 
p56~, p59f~,  and p63 are indicated. Figure 6.  A 62-kD tyrosine phosphorylated protein coimmunoprecipi- 
tares with GAP specifically  after CD2 stimulation  ofJurkat T cells.  Jurkat 
cells (107 cells for each point) were left unstimulated (lanes I  and 4), or 
were activated with the CD3 mAb UCHT1 for 1 min (lanes 2 and 5), 
or the CD2 mAb pair X11+D66 for 5 min (lanes 3 and 6). Cells were 
lysed in a lysis  buffer containing  1% digitonin  and the lysates immunopre- 
cipitated with anti-PI.C~-I mAb (lanes I-3) or anti-GAP mAb (lanes 4--6). 
Immunoprecipitates were then resolved on a 8% acrylamide gel and trans- 
ferred onto nitrocellulose. The membrane was then divided into two parts. 
(.4) Corresponds  to the upper part of the blot revealed with anti-GAP 
mAb. (/3) The lower part of the blot revealed with antiphosphotyrosine 
mAb 4G10. After ECL reaction,  exposure of the films was identical for 
A and B. Positions of GAP and p62 are indicated. 
p63 Coimmunoprecipitates with PLGT-1 and Is Distinct  from 
a Tyrosine  Phosphorylated Form of  p56  r  or p56f~ Kinases.  We 
have shown that p63 was specifically tyrosine phosphorylated 
after appropriate CD2 stimulation. That it may represent a 
link in the corresponding biochemical cascade was therefore 
possible. Thus, a possible important role for p63 to play in 
the CD2 transduction pathway would be to associate with 
PLC~,-1 after receptor stimulation. We have therefore exam- 
ined tyrosine phosphorylated proteins that coimmunopre- 
cipitated with PLC2r  after CD2 stimulation of Jurkat T 
cells. For that purpose, cells were incubated with Xll+D66 
for 5 rain before lysis and immunoprecipitation with anti- 
PLC3'-I mAb, and then probed with antiphosphotyrosine 
mAb. As shown in Fig. 5 a, the 63-kD tyrosine phosphorylated 
protein was found to coprecipitate with PI.C'y-1 after CD2 
ligation using the mitogenic pair Xll+D66.  As previously 
reported (4), p35/36 also coimmunoprecipitated  with PLCqr-1 
upon these conditions of CD2 stimulation. The other pro- 
reins present in the anti-PLCy-1 immunoprecipitate  were iden- 
tical in unstimulated or in CD2-stimulated  Jurkat cells. These 
results thus suggested that p63 formed a complex  with PLC3,-1 
and p35/36 after CD2 stimulation, even though these pro- 
teins were likely phosphorylated by distinct PTKs. Interest- 
ingly, we found that after Jurkat cell stimulation with D66 
mAb  alone,  p63  also  could be  immunoprecipitated with 
PLC3,-1 (Fig. 5 a) although, as we described above (see Fig. 
3 B), PLC'y-1 was not tyrosine phosphorylated in that ex- 
perimental condition. In parallel experiments, PLC3r  im- 
munoprecipitations were also performed after CD3 stimula- 
tion. As shown in Fig. 5 a the CD3-specific  66-109 tyrosine 
phosphorylated doublet was not detected in the anti-PLC3r 
immunoprecipitate  contrary to the PLC'y-l-associated tyro- 
sine phosphorylated protein p35/36. 
Figure 7.  Only p62 is highly tyrosine  phosphorylated  in GAP im- 
munoprecipitates after CD2 stimulation of Jurkat cells. (A)Jurkat cells 
(107 for each point) were left unstimulated (lane I), or activated with the 
CD3 mAb UCHT1 for 1 rain (lane 2), or the CD2 mAb pair Xll+D66 
for 5 min (lane 3). Cells were then lysed in a lysis'  buffer containing 1% 
digitonin and lysates immunoprecipitated  with anti-GAP mAb. Immune 
complexes  were resolved  by SDS-PAGE  on a 8% acrylamide  gel, and Western 
blot analysis  using antiphosphotyrosine mAb 4G10 was performed. After 
ECL reaction, exposure of the film was 1 min. (/3) The top of the same 
blot after a 5-min exposure of the film. 
Since p63 tyrosine phosphorylation occurred specifically 
after CD2 triggering, one could expect some physical associ- 
ation with its corresponding surface receptor.  However, we 
were repeatedly unable to coprecipitate p63 with the CD2 
mAb Xll (data not shown). This probably indicates that p63 
and CD2 did not associate or that their association was very 
weak, very unstable, or transient, since we have used digitonin 
as a detergent that allows mild lysis conditions and preserves 
protein interactions. 
The appearance  of slow migrating species of p56  ~  after 
CD2  stimulation of Jurkat  cells  has  been  reported  (16). 
Moreover,  it has been demonstrated recently that the CD2 
triggering could induce an increase in p56  ~  activity in the 
31.13 Jurkat cell variant (18). This suggested that p63 might 
be p56  k~ itself. Therefore, p56  ~  immunoprecipitation from 
the lysate of Jurkat cells stimulated with mAbs Xll+D66 
was performed and revealed using antiphosphotyrosine anti- 
bodies.  As shown in Fig. 5 b, no tyrosine phosphorylated 
species of p56  ~  were found to comigrate with p63 (com- 
pare lanes 2 and 3).  One has to notice that a few amounts 
of phosphotyrosine-labeled material appeared in the 56-kD 
region in the PLC~r  immunoprecipitate  of CD2-stimulated 
cells as compared with the control (compare lanes 1 and 2 
of Fig. 5 b). This could correspond to small amounts of tyro- 
sine  phosphorylated  p56  ~  coimmunoprecipitating with 
PLC3,-1, as recently shown in TCR-stimulated Jurkat cells 
(29). Similar conclusions arose from immunoprecipitation  ex- 
periments using anti-p59fr" antibodies since, once again, no 
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band after the stimulation of Jurkat cells with the couple of 
CD2 mAbs Xll+D66  (Fig.  5 b). 
The  62-kD  Protein Coimmunoprecipitating with  GAP  Is 
Specifically Tyrosine  Phosphorylated  after CD2 Stimulation of  Jurkat 
Cells.  A 62-kD protein has been described to be highly tyro- 
sine phosphorylated and to associate with GAP after signaling 
by tyrosine kinase growth factor receptor or in v-src tyrosine 
kinase-transformed  cells  (30).  We  therefore  investigated 
whether p63 could correspond to this protein. Cell extracts 
from CD3 or CD2-stimulatedJurkat cells were immunopre- 
cipitated in paralld with anti-PLC'y-1 or anti-GAP mAb, and 
the immune complexes probed in Western blot with GAP- 
specific mAb or antiphosphotyrosine mAb. As shown in Fig. 
6 A, GAP mAb recognized in Jurkat cells a band with a mo- 
lecular mass of 120 kD corresponding to one of the previ- 
ously described forms of mammalian p21ras GAP (31). This 
band was only present in GAP immunoprecipitates. Impor- 
tantly, we found in this experiment, as shown in Fig. 6 B, 
that a strong tyrosine phosphorylated 62-kD protein could 
be observed in anti-GAP immunoprecipitates from CD2- 
stimulated Jurkat cells (lane 6). This band was only weakly 
labeled in control or CD3-stimulated cells (Fig. 6 B, lanes 
4 and 5). Clearly, this protein comigrated with the band that 
we found recognized by antiphosphotyrosine mAb in the 
PLC3,-1 immunoprecipitate of CD2-stimulated Jurkat cells 
(Fig.  6 B, lane 3).  Taken together with the previous data 
showing that p63 was strongly tyrosine phosphorylated only 
after CD2 stimulation, these results thus suggested that p63 
might represent in fact the 62-kD GAP-associated  protein. 
Besides p62, another tyrosine phosphorylated protein of 190 
kD has been previously demonstrated to also associate with 
GAP (30, 32). Therefore, we investigated if p190 also could 
be differentially phosphorylated after CD2 and CD3 stimu- 
lation of  Jurkat cells. As shown in Fig. 7 A whereas p62 was 
found  heavily  and  specifically  labded  in  anti-GAP  im- 
munoprecipitates from CD2-stimulated cells, confirming the 
results of Fig. 6, only a very tenuous tyrosine phosphoryla- 
tion of p190 was observed that needed overexposure of the 
membrane to be evidenced (Fig. 7 B). Moreover, it was found 
tyrosine phosphorylated even in unstimulated cells. One has 
to notice here that only a weak tyrosine phosphorylation of 
GAP could be observed in paralld, as also shown in Fig. 7 
B. Interestingly, GAP appeared to be similarly phosphorylated 
in CD3- and CD2-stimulated cells. However, in contrast with 
p190, it was not tyrosine phosphorylated in unstimulated cells. 
These results ultimately suggest that in the so-called GAP 
complex,  only the  p62  protein is  highly tyrosine phos- 
phorylated upon CD2 stimulation of Jurkat T  cells. 
Discussion 
The necessity of the CD2 molecule as an alternative acti- 
vation pathway near the antigen-specific CD3-TCR complex, 
and its putative role, remain unknown. It has been shown 
that T  cell  activation through CD2 requires  a functional 
CD3-TCK complex at the cell surface (5, 8, 23, 33),  sug- 
gesting that signals triggered through these receptors were 
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transduced by the same way. According to this idea, it has 
been reported that stimulating T  cells with mAbs specific 
for CD3 or CD2 induces tyrosine phosphorylation of the 
same set of polypeptides (34). However, in contradiction to 
this, Jin et al. (35) demonstrated in Jurkat cells that CD3- 
TCK and CD2 pathways should be distinct since a 68-kD 
tyrosine phosphorylated protein was induced after CD3 but 
not CD2 stimulation. In the same way, recent studies in rat 
thymocytes revealed that different tyrosine phosphorylated 
proteins could be coimmunoprecipitated  with CD3 or CD2 
molecules (36).  Here  we  provide evidence  that  different 
pathways could be activated depending on whether or not 
Jurkat T cells were stimulated through the CD3 or different 
epitopes of the CD2 molecule. 
Numerous substrates are tyrosine phosphorylated after CD3 
or CD2 stimulation ofJurkat T cells using a mitogenic pair 
of CD2 mAbs (28, 37). The identity of most of these tyro- 
sine phosphorylated proteins is not yet known, except for 
some of them, such as PLCqr-1, the CD3~" chain (38),  the 
p95  ray protooncogene (39),  or the kinases  p56  ~k (16, 18), 
pS~  (19), and ZAP-70 (20). The tyrosine phosphorylation 
of many of these proteins, including PLC~/-1 and a 35/36- 
kD phosphoprotein previously shown to be associated in a 
stable complex (4), appeared to be common to both stimuli 
and was found to correlate with the rapid production of ino- 
sitol phosphates leading in both cases to intracellular flee cal- 
cium increases. This suggested that these substrates  might 
be phosphorylated by the same tyrosine kinase, an assump- 
tion further strengthened by the finding that, as also shown 
in this report (Fig. 1), these proteins shared for a given stimulus 
an identical tyrosine phosphorylation kinetic. This PTK should 
be activated after CD3 or CD2 stimulation, and should there- 
fore belong to a common signal transduction pathway. 
Our results showed that besides this common pattern of 
tyrosine phosphorylated proteins, an additional 63-kD band 
could be induced specifically after CD2 triggering of Jurkat 
cells using different pairs  of CD2 mAbs. Importantly, the 
tyrosine phosphorylation of p63 could be dissociated for the 
tyrosine phosphorylation of the PLC~/-1-p35/36 complex as 
evidenced when using a mAb directed against the D66 epi- 
tope of the CD2 molecule. Accordingly, no IP production 
or calcium response (data not shown) was induced in that 
case. This result suggested that tyrosine phosphorylation of 
p63 on the one hand, and of the PLC3,-1-p35/36 complex 
on the other, occurred through distinct PTKs activated after 
CD2 stimulation ofJurkat T cells. Interestingly, our results 
may lead to a similar conclusion for the CD3 pathway with 
regard to our finding of a 66-kD tyrosine phosphorylated 
doublet only after CD3 stimulation. Indeed, tyrosine phos- 
phorylation of this doublet was not induced when using a 
comitogenic pair of CD2 mAbs, whereas as previously men- 
tioned, the whole pattern was similar to the one obtained 
after CD3 activation.  This 66-kD doublet could represent 
the CD5 surface antigen since CD5 appears as a 67-69-kD 
doublet which is tyrosine phosphorylated by CD3 in Jurkat 
T cells (40-42). Of course, it can be also hypothesized that 
the same kinase would be associated with CD3 and CD2 
and would phosphorylate either p66 or p63 as a consequence of the exclusive association of p66 with CD3 and p63 with 
CD2.  However,  our experiments with  the CD2+CD3 - 
31.13 Jurkat cell variant supported the idea of a distinct ki- 
nase activated  after CD2 triggering. 
As mentioned above, T cell activation through CD2 has 
been previously shown to require functional CD3-TCR com- 
plex at the cell surface, and especially functional CD3~" chain 
(8), thus supporting the classical assumption of a common 
CD3-CD2 signaling pathway.  Accordingly, tyrosine phos- 
phorylation of the PLC~/-1-p35/36 complex could not have 
been induced in the ~'-negative 31.13 variant either with CD3 
mAb or a mitogenic pair of CD2 mAbs. However, the iso- 
late tyrosine phosphorylation of p63 was still observable after 
cell stimulation through the CD2 molecule, demonstrating 
that this CD2-dependent tyrosine kinase pathway was dis- 
tinct from the tyrosine kinase pathway(s) linked to the CD3 
molecular complex. We do not know which kinase is actu- 
ally involved in the phosphorylation of p63. p56  k~ might be 
one candidate.  Indeed, this kinase has been demonstrated to 
still be activated via CD2 in the 31.13 variant (18). However, 
if this is true, then p63 also should be present after CD3 stim- 
ulation in the Jurkat wild-type line since this stimulus has 
been reported, although this is a very controversial problem, 
to  activate  p56  ~k  (18). Concerning the  two  other PTKs 
which are clearly involved in the human T cell activation pro- 
cess, p59fr" and ZAP-70, both have been demonstrated to be 
associated with the CD3 molecular complex and especially 
with its ~" chain (19, 43). Thus, according to the results ob- 
tained in the 31.13 variant, their contribution to p63 phos- 
phorylation is unlikely. 
Questions  remained  about  p63  identity.  We  initially 
thought that it  might be p56  ~  itsels  Indeed,  slow mi- 
grating species of the enzyme have been evidenced after CD2 
stimulation in Jurkat cells. Moreover, as noted above, the CD2 
triggering still induced an increase in p56  ~k kinase activity 
in the Jurkat cell variant 31.13 (18). However, using immu- 
nopredpitation experiments, we found that in CD2-stimulated 
cells, the highest slow migrating tyrosine phosphorylated spe- 
cies of p56  ~  did not comigrate with p63, suggesting that 
this one might be a distinct protein. In the same way, the 
p59f~ kinase did not comigrate with p63, eliminating the 
possibility that they could be identical.  This question about 
an identity between p56  ~k and p63 was reconsidered by our 
finding that, at least, PLC3~-I, p35/36, and p63 were found 
to be associated after CD2 stimulation with a mitogenic com- 
bination of mAbs. It has been shown recently using a PLC~/- 
1-containing fusion protein, that a small amount (<5%) of 
tyrosine phosphorylated p56  k~ could associate with PLC7-1 
after Jurkat cell stimulation with a TCIL-specific mAb (29). 
Accordingly, it appeared  from our experiments that small 
amounts of p56  ~ labeled by antiphosphotyrosine antibodies 
could be immunoprecipitated  with PLC3,-1 after CD2 stim- 
ulation of Jurkat cells (Fig. 5 b, lane 2; the p56  ~  comigra- 
ting doublet over the Ig band), a result further confirmed 
by in vitro kinase assays (data  not  shown). But  no p63- 
comigrating forms could be again observed in this latter ex- 
periment. Interestingly,  we found that immunoprecipitation 
of p63  by  anti-PLC~-i  also  could be  achieved  in  D66- 
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stimulated  Jurkat cells, in a stimulation system where no de- 
tectable tyrosine phosphorylated PLC',/-1 has been observed. 
This indicates that p63 associates at least in part with non- 
phosphorylated PLC'y-1, and could therefore represent a pro- 
tein that regulates PI.C3,-1 during the CD2 T cell activation 
process. 
We have further hypothesized that p63 could represent the 
p62 GAP-associated protein. Our results demonstrate the pres- 
ence of a highly tyrosine phosphorylated 62-kD protein coim- 
munoprecipitating with GAP in ]urkat T cell extracts  after 
CD2 stimulation. At the same time, GAP was much less tyro- 
sine phosphorylated. These findings were in complete agree- 
ment with the results recently obtained by Gold et al. (44) 
in B lymphoma cell lines after mIg cross-linking, p62 was 
first  discovered  in  oncogene tyrosine kinase-transformed 
fibroblasts such as v-src or v-fps (30). In these cells, p62 was 
found to be constitutively and highly tyrosine phosphorylated 
without cell stimulation and to coimmunoprecipitate with 
GAP. Tyrosine phosphorylation of p62 and coimmunoprecipi- 
tation with GAP was also dearly evidenced in rat fibroblasts 
transfected with the human EGF receptor, but only after EGF 
stimulation (30). The same results were obtained in EBV im- 
mortalized B cells stimulated with an anti-IgM mAb (44). 
Taken together, these results suggest that p62 was a preferential 
substrate of transforming or mitogenic tyrosine kinases. This 
would probably explain why the tyrosine phosphorylation 
of p62 appeared to be so strong in Jurkat cells as compared 
with peripheral blood T cells. Indeed, in these cells, proteins 
migrating in the 66- and 63-kD regions were always very 
weakly labeled, and the imbalance between the CD3 and the 
CD2 activation pathway in stimulating the tyrosine phos- 
phorylation of p63 was very difficult to evidence (data not 
shown). It is thus possible that this event represents in physi- 
ological T cells a phenomenon that is difficult to detect and 
that is greatly enhanced in Jurkat cells, presumably as a con- 
sequence of the malignant transformation and/or deregulated 
activities of the responsible kinases. This assumption would 
be in agreement with the fact that p62 was found to be highly 
phosphorylated only in transformed cells (45). Interestingly, 
we observed that tyrosine phosphorylated p62 could not be 
recovered from GAP immunoprecipitates  performed on CD3- 
stimulated Jurkat cells. In addition to the fact that this is 
an additional argument for an identity of p62 with the PLC3~- 
1-associated  63-kD  protein,  this ultimately suggests that 
different regulations of the ras/GAP pathway between CD2 
and CD3 may take place in Jurkat cells. Indeed, p62 binding 
to GAP protein is thought to inhibit its GTPase activity, thus 
favoring the maintenance of the activated form of p21ras (46). 
How p62 would associate with PLC-y-1 is an as yet unresolved 
question. However,  tyrosine phosphorylated p62 has been 
demonstrated to associate with GAP through its SH2 do- 
main (46). A similar mechanism therefore might be involved 
in its association  with PLC3'-I, which also contains such 
domains. 
A full activation process through the CD2 molecule in 
vitro needs the simultaneous use of two antibodies directed 
against distinct epitopes of the molecule. Thus far, it has been 
speculated  that this peculiarity would reflect the existence 
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confirmed  by the findings that two different molecules, CD58 
(LFA3) and CD59, could bind specifically to CD2. Indeed, 
whereas CD58 binds with a high affinity to the CD2 epi- 
tope recognized by a mAb such as Xll, which defines an 
external epitope of the molecule, it is now suggested that 
the CD59 molecule would bind to another epitope on the 
CD2 receptor (3) and would have potentiating effects with 
CD58 on T  ceU activation (47).  One intriguing problem, 
however,  when discussing the possible function of CD2, is 
that it represents one of the earliest call-surface  markers to 
appear during ontogeny. Thus, early prothymocytes which 
further differentiate to mature T  cells express CD2. How- 
ever, they do not express CD3-TCR on their membrane. In 
these cells, although CD2 does not trigger intracellular cal- 
cium elevation or IL-2 synthesis, it induces nevertheless pro- 
tein tyrosine phosphorylation, suggesting that CD2 would 
in addition to its coreceptor function, play its own role in 
T  cell activation (48). Our results open new prospects con- 
cerning a putative CD2-dependent biochemical cascade in- 
volved in T cell differentiation. Alternatively, this may rep- 
resent a specific CD2-1inked regulation pathway of T  cell 
activation, since p62 is believed to contribute to p21ras acti- 
vation and since it was shown to associate with PLC~/-1 upon 
CD2 stimulation. 
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